Mike Huckman
Mike Huckman is CNBC’s Pharmaceutical Reporter covering the drug, biotechnology and medical device industries. Huckman is based at the network’s global headquarters in Englewood Cliffs, N.J.
Huckman joined CNBC in September 2000 after nine years at WXYZ-TV in Detroit where he was one of the station’s lead reporters. Prior to WXYZ-TV, he served as a general assignment reporter at KGUN-TV in Tucson, Ariz., KBCI-TV in Boise, Idaho, and as an anchor/producer for the Montana Television Network.
Huckman has won numerous awards for his reporting, including three Michigan News Emmys, one for Business and Financial reporting, as well as a first place News Series Award from the Michigan Association of Broadcasters. Huckman earned a Bachelor of Arts degree in journalism from the University of Southern California.
Mike Huckman's Latest Articles
- A Biotech Bonanza for ImClone and Dendreon
- Is Eli Lilly ImClone's Secret Bidder?
- Eli Lilly, ImClone: The Waiting Game Continues
- Eli Lilly Moves on News of Its New Bloodthinner
- Abbott, Boston Scientific: Rising Stent Stars
-
Are Dendreon's "Naked Shorts" Running For Cover?
on Sep 18, 2008 about DNDN
- ImClone's Icahn Is Holding a Pistol to Bristol
- A Delay and a Deal for Pfizer
- Fannie, Freddie & Pharma: Does Resolution Help Sector Stocks?
- Eli Lilly's Brewing Battle With Bristol-Myers
- Five Presentations from the Recent Biotech Investment Conference
- Pfizer's Found Innovation at Medivation
- Has Lilly's Effient Been FDA Approved?
- Is a Hurricane Lurking for Merck and Schering-Plough?
-
Merck's Charm Offensive for Gardasil
on Aug 29, 2008 about MRK
- Five Biopharma Companies Drop on Negative Drug News
- Drug Safety Updates For Elan, Biogen, Amylin, and Lilly
-
AstraZeneca Begins Its Flu Campaign Season, and Pharma Donates to Candidates
on Aug 26, 2008 about AZN
- The Genentech Guessing Game - What Will Roche Offer Next?
-
Alnylam Pharmaceuticals: A Falling Star
on Aug 21, 2008 about ALNY
- AstraZeneca Gives FluMist Spray a Shot in the Arm
- Abbott Labs Beefs Up Its Drug Portfolio and Stent Business
- Updates on the Healthcare/Biotech Mergers
- Are Big Pharma's Dollar Days Nearly Over?
- By How Much Will Roche Increase Its Valuation for Genentech?
- Eli Lilly Sells Lab Site to Covance
- ImClone - Bristol-Myers Merger: The Negotiations Begin
- So Much for the Summer Doldrums with Drugmakers
-
Amgen's D-mab Delights Investors
on Jul 29, 2008 about AMGN
- The State of Statins and Stents
-
Viagra Sales Drop: Is It the Economy, or Is Pfizer Losing Market Share?
on Jul 25, 2008
-
Is Pfizer's Viagra Suffering with the Economy?
on Jul 24, 2008 about PFE
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
- About Seeking Alpha
- About Us
- Contact Us
- What's New
- Readers Feedback
- Contributors
- Contribute an Article
- Feature Your Book
- Our Contributors
- Anonymous Contributions
- Dispute an Article?
- Tools & Widgets
- Stock Market Toolbar
- Stock Search Add-on
- Power Search
- Email Alerts
- Live Feeds (RSS)
- Legal
- Terms of Use
- Privacy
- Copyright
- Advertise
Want to talk to our community?
Got something interesting to say?
- Advertise with Us

Latest Commentson Mike Huckman's Articles